Chinese medicinal compound delisheng has satisfactory anti-tumor activity, and is associated with up-regulation of endostatin in human hepatocellular carcinoma cell line HepG2 in three-dimensional culture

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 41

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

267

HTML

1949

Figures (1-8)

296

Tables (1-5)

200

Sum=2712

Nov 7, 2007 (publication date) through Nov 4, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Liver Cancer

World J Gastroenterol. Nov 7, 2007; 13(41): 5432-5439
Published online Nov 7, 2007. doi: 10.3748/wjg.v13.i41.5432

Table 5 VEGF expression of multicellular spheroids with treatment of delisheng, 5-fluorouracil, adriamycin and PBS

^aP > 0.05 5-fluorouracil vs delisheng,

^cP > 0.05 adriamycin vs delisheng,

^eP > 0.05 PBS vs delisheng.

Citation: Cui J, Nan KJ, Tian T, Guo YH, Zhao N, Wang L. Chinese medicinal compound delisheng has satisfactory anti-tumor activity, and is associated with up-regulation of endostatin in human hepatocellular carcinoma cell line HepG2 in three-dimensional culture. World J Gastroenterol 2007; 13(41): 5432-5439
URL: https://www.wjgnet.com/1007-9327/full/v13/i41/5432.htm
DOI: https://dx.doi.org/10.3748/wjg.v13.i41.5432